Exam 2 Flashcards
(96 cards)
Lecture 12
Hepatobiliary Diseases
Acinus Model
Zone 1 Cells
-Protein synthesis
-Urea, cholesterol production
-Gluconeogenesis
-Bile formation
-Beta oxidation of fatty acids
-Most oxygen area
Zone 2
-Produce albumin
-Glycolysis
-Pigment formation
Zone 3
-Liponeogenesis
-Ketogenesis
-Drug metabolism (P450)
-Most susceptible to toxins and lowest in oxygen supply (Centrilobular) - Hypoxic damage
Signs & Symptoms
- Abdominal enlargement
-Ascites and or hepatomegaly, organomegaly - Microhepatica
-Chronic disease
-Cirrhosis - Diarrhea
-Cholestasis: decreased bile acids secretion, decreased fat ingestion/absorption - hyper osmosis
-Portal vein hypertension: decreased water absorption from GI - Vomiting
-Shunting: increased toxins activate CRTZ, hepatomegaly or biliary obstruction: increased vagal tone - Icterus
-Decreased clearance of bilirubin - Hepatic encephalopathy
-2nd to congenital or acquired PSVA, Cats: HE 2nd to hepatic lipidosis without shunting (lack of AA) - PU/PD
-HE: abnormal neurotransmission stimulate ACTH production increased cortisol
-Decreased urea production medullary washout
-Vomiting and diarrhea - Dysuria
-From urolithiasis (ammonium biturate) - Anesthesia intolerance
-Decreased hepatic metabolism, avoid GABA-ernig drugs (ie. benzodiazepines) - Alcoholic feces
-Signs of endocrine pancreatic insufficiency (pale grey), but patients different
-Extra hepatic bile duct obstruction - Hypoglycemia
-Young animals, no glycogen stores
-Portosystemic shunt older animals, synthetic hepatic failure or hepatic neoplasia-insulin like growth factor - GI bleeding
-Portal hypertension, coagulopathies, DIC
Abdominal enlargement - Ascites
- Abdominal muscle weakness
- Organomegaly: hepatomegaly, hepato-splenomegaly
- Abdominal effusion/ascites
-Transudare or modified transudate
-Exudate
-Hemorrhagic
-Chylous
Ascites/edema mechanisms
1. Decreased oncotic pressure (low albumin)
2. Vasculitis: leaking vessels
3. Increased hydrostatic pressure (venous obstruction, volume overload)
4. Lymphatic obstruction
Ascites & Liver
-Low to moderate protein
-Low to moderate cell count
-Transudate (pure or modified)
Primary Ddx for Transudate
- Heart disease
- Hepatic disease
- Marked hypoproteinemia associated with decreased production and or excessive loss
- Vasculitis: unusual
Pre hepatic Ascites
-Portosystemic shunt (acquired)
-Portal vein obstruction or hypoplasia
Intrahepatic
-Fibrosis/cirrhosis
-Microvascular shunting/intrahepatic shunt
Post-hepatic “passive hepatic congestion”
-Obstruction of intrathoracic caudal vena cava
-Congestive heart failure
-Pulmonary hypertension
-Pericardial disease
RAAS activation
-Pooling of blood in the splanchnic circulation secondary to portal hypertension
-Decrease in cardiac output activates the RAAS
-This leads to volume expansion, an increase in hydrostatic pressure, and this worsens ascites
Ascites - Hypoalbuminemia
-Associated with advanced liver disease
-Lowers vascular osmotic pressure further aggravating ascites formation
-Ascites associated with chronic hepatitis is a poor prognostic indicator
Microhepatica
Jaundice = Icterus
-Bile pigment (bilirubin) staining of tissues
Mechanisms
1. Large, persistent increase of bilirubin (hyperbilirubinemia), exceeds capacity o liver to take up and excrete it
2. Major impairment of bile excretion. Cholestasis with hyperbilirubinemia
Cholestasis
-Inability to take up, process within the hepatocytes or excrete bilirubin into the bile canaliculi are primary causes of cholestasis in liver disease.
-Obstruction of bile duct near duodenum, such as thrombus, cholelith, extraluminal compression (tumor or swelling due to inflammation), pancreatitis
-Jaundice may or may not be present depending on degree of stasis or blockage
Bilirubinuria
2+ to 3+ on dipstick
May be normal in concentrated urine for dogs (especially intact males)
-Bilirubinuria in cats is always pathologic due to their high tubular resorptive capacity 9x >dogs
-Rising bilirubinuria often precedes onset of icterus
Hepatic Encephalopathy
-Abnormal mentation, gait, neurologic function
-Accumulation of toxins in the blood
1. Marked reduction of functioning hepatic mass to process toxins
2. Portal blood flow is diverted around the liver via portosystemic shunting (congenital shunt)
Clinical syndrome
Type A
-Acute hepatic failure in the absence of pre-existing liver disease (Hepatic lipidosis in cats)
Type B
-Associated with congenital PSS
Type C
-Marked hepatic parenchyma disease and portal hypertension or acquired PSS, and divided into episodic, persistent, and minimal subcategories
HE, Ammonia theory
C/S
-Hypersalivation: especially cats with hepatic lipidosis. Dogs with advanced disease
-Polyuria in dogs: neurotransmitter changes imparing dopaminergic ACTH impaired release due to reduced inhibition of pituitary
-High cortisol throughout to induce partial inhibition of renal tubular response to vasopressin
Grading
1. Asymptomatic
2. Mild increase inapthy, decrease motility, or both
3. Mild ataxia, severe apathy
4. Combination of ptyalism, severe ataxia, head pressing, circling
4. Coma, seizures, stupor
C/S
-Reflective of diffuse (bilateral) cerebral cortical dysfunction
-Often episodic
-May be precipitated by a meal
-Reversible with treatment of underlying hepatopathy
Pathogenesis
-Not fully understood
Theories - Ammonia
-Biggest toxin implicated
-Ammonia detoxification mainly performed in liver via portal circulation unless shunt present
-Urea cycle: ammonia into urea in periportal hepatocytes and urea excreted by the kidneys
Brains lacks effective urea cycle
-Hyperammonia, glutamine formation increases
-Ammonia metabolized to glutamine in astrocytes by ATP
-Cellular swelling, neuronal edema, formation of reactive oxygen and nitrogen species.
-In cats with lipidosis, arginine deficiency leads to hyperammonemia
-Ammonia plays a role in regulation of GABA and Glutamate
Endogenous Benzodiazepines, Manganese, Pro-inflammatory cytokines
Benzodiazepines
-Biggest category of anesthesia meds
-Problem when liver function is compromised
-HE liver makes compound that act like diazepam and valium
-GABA inhibitory neurotransmitter regulated by GABA/benzodiazepine receptor/chloride ionophore complex
-Chloride ionophore complex-receptors for barbiturates and ivermectins. Receptor binding allows chloride to enter the cell
-Benzodiazepine-like ligands increased in plasma of human patients with fluminant liver failure
-Concentration of ligands correlated with severity of HE
-40% of cirrhotic human patients in hepatic coma responded to FLUMAZENIL
-Source of benzodiazepine unknown (food?)
Manganese
-Essential trace element
-Decreased hepatobiliary excretions with PSS
-Toxic to basal ganglia: astrocytes area sire of early destruction dysfunction/damage
Pro-inflammatory Cytokines
-Strong positive correlation
-TNF-alpha and severity of HE in patients with cirrhosis
-Dogs with cPSS and HE have significantly higher serum [CRP] than asymptomatic dogs with cPSS
HE - Predisposing factors, Prognosis
-High protein meal
-GI bleeding bc RBCs are treated as protein in the gut, ammonia and amine acids in RBCs
-Azotemia
-Hypokalemia
-Alkalemia
-Blood transfusion
-Bacterial infection: increases nitrogen load
-Sedatives, anesthetics, organophosphates
-Diuretics: secondary hypokalemia and azotemia
-Methionine: converted to mercaptans by GI bacteria
Arginine deficiency in CATS
Prognosis
-Fair to good for mild cases
-Guarded to poor with more severe C/S
-Varies depending on whether the underlying cause can be successfully treated
-Extrahepatic PSS good with surgical therapy
Poor if
-PT>100 seconds
-Hyperbilirubinemia
-Aflotoxin toxicosis
-Very young or very old
-Viral infections
Causes of death HE
-Edema
-Sepsis
-Hemorrhage
Coagulopathies
Liver synthesizes
-Protein C, S
-Antithrombin
-Fibrinogen, plasminogen
-Vit-k dependent factors: VII, IX, X, II (prothrombin)
-Factors V, XI, XII, XIII
Vitamin K deficiency when bile flow is decreased
75-85% factors not functioning or present before coagulator function is prolonged
-Thrombocytopenia can be observed due to consumption or sequestration
Bleeding risk assessment is important in clinical work-up of the hepatic patient
-Conversely, dogs and cats with hepatic disease may occasionally be predisposed to hypercoagulability. This may lead to microvascular thrombosis or portal vein thrombosis
-Bleeding can occur with portal hypertension-induced vascular fragility
-Hematemesis and melena may be seen with hepatic disease
-Upper GI most commonly affected
Metabolic Disturbances
Hypoalbuminemia
-Associated with hepatic production >/= 80% loss
-Hypoglycemia: decreased gluconeogenesis, severe PSS or hepatocellular dysfunction, possible neoplasia
Lecture Diagnostic tests Hepatobiliary diseases
History, Signalment, PE
Laboratory testing - CBC
-Few changes are consistent with hepatobiliary disease
-Normochromic to mildy hypochromic microcytosis (decreased MCV) = iron deficiency, unable to use iron available, such as in cirrhosis or PSS
>60% dogs PSS
<30 % cats PSS
Ddx: GI bleeding or breed specific
Anemia
-Mild microcytic anemia - consider PSS
-Marked microcytic anemia - consider GI bleeding
-Regenerative, microcytic anemia in jaundiced patient: consider hemolytic anemia (immune, infectious)
-RBC morphology: related to altered lipoprotein metabolism in cell membrane abnormalities
-Poikilocytes (abnormally shaped RBCs): particularly in cats with PSS or other hepatobiliary disease
Serum Enzyme Activity
ALT (SGPT) & AST
-Present in the hepatocyte cytosol and are released as a result of hepatocellular membrane damage LEAKAGE
-Specific to hepatocellular injury
-Alanine transaminase, Serum glutamic pyretic transaminase.
Related to extent of hepatic injury but not necessarily prognosis/reversibility
-Generalized hypoxia, regeneration, and metabolic activity also increase ALT levels
-Glucocorticoid activity in dogs mild to moderate increase in ALT
AST (SGOT)
-Aspartate transaminase
-Glutamic oxaloacetic transaminase (SGOT)
-Not liver specific
-Found in muscle also
-Consider in reference to Hx, c/s, and muscle specific enzyme activity Creatine kinase (CK or CPK)
-AST more reliable in cats for hepatocellular damage prediction
SAP (ALP) and GGT
SAP, ALKP, ALP: Alkaline Phosphatase
-Low concentration in the hepatocellular cytosol, so not leakage associated
-Not specific but association in cholestasis
-Found in bone, GI tract, kidney, and placenta
Glucocorticoids, phenobarbital, induction ALP in dogs
Increased level always significant in cats
-Growing bones, young dogs, common elevation
-Are serum enzymes that reflect new synthesis and release of enzymes from the biliary tract in response to certain stimuli such as cholestasis
GTT
-Gamma-glutamyltransferase
Specific for cholestasis in dogs and cats
-Post hepatic cholestasis and diseases affecting the biliary tree association
-Longer half life than ALKP in cats, so it is useful for monitoring treatment and progression of biliary disease
What tests estimate hepatic function?
- Glucose
- Cholesterol
- Albumin
- BUN
Functional testing - Bile Acids
Serum Bile Acids
Bile Acid Stimulation Test
-Collect a 3ml sample of blood in a serum tube after animal was fasted for 12 hours
-Feed a small amount of food that is normal in fat content (~20% fat dry matter basis in dogs)
-Collect another sample 2 hours after the meal
-Generally, postprandial abnormal SBA concentration using the enzymatic method in animals without icterus exceeds 20umol/L in cats and 25 umol/L in dogs
Urine Bile Acid (UBA)
-Reflects the average SBA concentrations during that time interval of urine formation
-Random UBA sampling has the advantage of nor requiring timing to meals or enterohepatic challenge
-UBA elevations correlate with hepatobiliary disease and PSS in dogs and cats
-Do not correlate as well for hepatic neoplasia in the dog compared to SBA
Functional test - Ammonia
- A high ammonia concentration helps in confirming suspicion of HE
-Reduced hepatic mass available to process ammonia
-Presence of portosystemic shunting, which disrupts the presentation of ammonia to the liver for detoxification
-Overproduction of ammonia in the GI tract (ie, SI bacterial overgrowth)
Ammonia Testing
-Pretest: draw after fast of minimum 6 hours - 12 hours
-Then feed a meal of 25% daily caloric requirement
-Post test draw 6 hours after a meal, must be collected in iced, heparinized (green top tube) and spun immediately in a refrigerated centrifuge and separated
-Canine samples - assay within 30 minutes
-Feline samples can be frozen (-20 degrees Celsius, and assay within 48 hours)
Coagulation Tests
APTT & PT
-Both prolonged if impaired liver function
-Thrombocytopenia is not uncommon in hepatobiliary disease, may be secondary to bleeding (GI), consumption (DIC), and or decreased production
-Ideally platelet function should be assessed prior to biopsies of the liver
-Buccal mucosal bleeding test (BMBT) is the only cage side test available to practitioners, but should be interpreted with caution